This invention relates to wearable collector devices and methods for noninvasive sampling of exhaled breath biomarkers, pathogens or viral loads.
Diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the coronavirus pandemic (COVID-19) remains time-consuming and a challenge for clinicians and researchers. Most of the patients are asymptomatic until advanced stages when individuals experience severe symptoms. However, in the early stages, when infected patients are asymptomatic, the virus spreads through breath to other individuals without their awareness.
Without the capacity to accurately quantify who is infected, governments have established large-scale quarantine measures that have had catastrophic effects on the global economy. Constant screening in the general population and healthcare professionals would enable early detection of asymptomatic patients.
The current gold standard method to determine if a patient is infected with SARS-CoV-2 relies on amplifying the virus' genetic material using quantitative reverse transcription polymerase chain reaction (RT-PCR). Other approaches include the use of lateral flow immunoassays (LFIs) based on anti-coronavirus antibodies (IgG and/or IgM) or CRISPR technology to detect SARS-CoV-2. Nevertheless, the antibody-based methods cannot detect the current status of infection, while CRISPR based technology is not implemented for routine diagnosis. Recent works have reported the development of portable sensors for saliva or nasopharyngeal swab.
Despite their great utility, one of the main bottlenecks when screening patients is the type and method of sampling. Current sampling methodologies include collecting nasopharyngeal swabs, blood or saliva, in sterile containers. These sampling methods can cause patient discomfort (nasal swabs and needles) and, in some cases, requires extra processing steps for isolating the few viruses present in it (saliva). On the other hand, aerosol or filter samplers rely on long-term exposure for sampling, leading to time-dependent virus collection and enrichment compared to one-time sample collection as happens with nasopharyngeal, blood or saliva. Such sampling devices have been crucial to understanding virus generation due to their high sensitivity and isolation capabilities. However, most of these collectors are bulky, have long sampling time requirements, and require trained professionals to perform sampling.
The present invention provides technology to address at least some of these shortcomings and concerns.
The present invention provides a wearable breath-based noninvasive sampler patch allows collecting large quantities of virus/pathogens over prolonged periods of time combining the resilience and commodity of a disposable test. In one example, the wearable breath-based noninvasive sampler integrates a detachable (medical) adhesive and a porous membrane for target enrichment in the sample. This wearable breath-based sampler is attached on the inner surface of face-covering and collects large quantities of viruses over prolonged periods of time. The flexible device is compatible with any mask or protective equipment, can sustain constant mechanical deformation, and can be made in large quantities. After sampling, the enriched pathogen was extracted from the collector for further gold standard analytical evaluation. (RT-PCR, LAMP).
In one embodiment, the surface can be integrated with various sensors to detect the targets quantitatively and/or qualitatively on the surface itself and outcomes can be noticed via visual indicators detectable to the naked eye or via quantitative tools externally.
Embodiments of the invention have advantages over existing devices and methods in that they are stand-alone collector devices for personal use, non-invasive when compared to nasal swabs, low-cost and make scalable fabrication possible adaptable to any type of protective mask.
In one embodiment, the invention is a wearable collector device to collect biomarkers, pathogens, or viral loads through exposure from breath-derived droplets. The wearable collector device has a single piece flexible substrate 100 which distinguishes a mask attachment section 110 and a collector attachment section 120 situated below mask attachment section 110 (
A double-sided adhesive 310 is sized to fit a side of mask attachment section 110. One side of adhesive 310 is suited to adhere to the side of mask attachment section 110, and the other side of adhesive 310 is suited to adhere to an inner surface of a mask as shown in
A membrane 400 is sized to cover at least the open area 122 of the collector attachment section 120.
The membrane can be made out of polycarbonate, nitrocellulose, aluminum oxide, or the like. The pore size of the membrane is in the range of 50 nm-5 μm and should be capable of collecting biomarkers, pathogens, or viral loads through exposure from breath-derived droplets.
The wearable collector device could be outfitted with sensor preferably in conjunction with the membrane to detect the biomarkers, pathogens, or viral loads. For instance, the collector could be integrated to with colorimetric, electrochemical, or optical sensors among others. The wearable collector device could further be outfitted with visual indicators to visualize detection of collected levels of the biomarkers, pathogens, or viral loads. For instance, the collector could be coupled with a lateral flow assay indicating the presence of a specific target.
The wearable collector device can be adhered to the inner surface of a face-covering as described above and is then ready to be used. A preferred time frame for usage is from minutes to hours range, with larger collection times providing a higher quantity of captured biomarkers. When ready the wearable patch as a whole or only membrane can be removed from the face covering and then membrane can be analyzed and e.g. be tested for SARS-CoV-2. Various tests can be performed, which are know in the art, such as e.g. polymerase chain reaction, loop-mediated isothermal amplification and immunoassays.
Additional teachings, embodiments and/or data can be found in U.S. Application No. 63/181,049 filed Apr. 28, 2021 to which this application claims the benefit for priority, and which is hereby incorporated by reference for all that it teaches.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/024681 | 4/13/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63181049 | Apr 2021 | US |